RPID
Rapid Micro Biosystems Inc
1.10$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Rapid Micro Biosystems Inc (RPID) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 10 | Q2 10 | Q3 10 | Q4 10 | Q1 11 | Q2 11 | Q3 11 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -8.3 | -8.3 | -8.7 | -8.8 | -5.2 | -11 | -12 | -19 | -13 | -17 | -15 | -15 | -12 | -17 | -9.2 | -9.7 | -9.5 | -16 | -10 | -8.6 | -9.9 | -9.1 | -9.7 | -9.1 | -3.2 | -15 | -13 | -40 | |
| – | – | – | – | – | – | – | 0.5 | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | 0.7 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 3.0 | |
| – | – | – | – | – | – | – | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.6 | 0.7 | 1.0 | 1.3 | 0.7 | 1.1 | 1.2 | 1.2 | 1.3 | 1.0 | 1.1 | 1.2 | 0.9 | 0.7 | 1.0 | 1.2 | 1.1 | 0.6 | 1.2 | 1.3 | 4.3 | |
| – | – | – | – | – | – | – | 0.4 | 3.0 | 0.7 | – | 12 | – | 12 | 0.7 | 1.3 | 1.5 | 0.9 | 1.1 | 1.0 | 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -1.2 | -1.2 | -2.8 | -1.3 | 4.3 | -1.3 | -0.6 | -6.7 | 0.6 | -3.7 | -4.0 | -0.4 | 2.8 | -4.6 | 3.1 | 1.9 | 0.1 | -4.0 | 0.5 | 0.8 | -2.1 | -0.3 | -0.5 | 0.0 | 6.9 | -3.2 | -2.2 | 1.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 | 0.3 | 0.5 | 0.5 | 2.0 | 2.4 | 2.0 | 1.6 | 0.8 | 0.8 | 0.2 | 0.5 | 0.4 | 0.6 | 0.5 | 0.2 | 0.1 | 0.3 | 0.4 | 0.1 | 0.1 | 0.4 | 0.2 | 0.8 | |
| – | – | – | – | – | – | – | -0.1 | -0.1 | -25 | -0.2 | 9.9 | 9.7 | 4.5 | -0.5 | -27 | -100 | 2.2 | -8.9 | 13 | 13 | 13 | 4.8 | 10 | 14 | 25 | -6.5 | 4.9 | 11 | 9.3 | -9.6 | 3.9 | 8.6 | 4.2 | 7.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.2 | – | – | – | 0.2 | 0.1 | – | – | 0.0 | 0.2 | – | 0.1 | – | 0.1 | – | 0.2 | – | – | 0.1 | – | |
| – | – | – | – | – | – | – | 9.5 | 7.0 | -26 | – | -26 | – | -26 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 20 | 0.0 | 0.0 | 0.0 | 20 | |
| 0.2 | 1.4 | 1.5 | 1.8 | 2.3 | 2.8 | 3.0 | 9.5 | 9.5 | 55 | 0.0 | 0.0 | 80 | -1.4 | 139 | -1.3 | 0.5 | 0.0 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | 0.0 | 0.4 | -0.3 | 19 | 0.4 | 0.2 | 9.4 | 29 | |
| – | – | – | – | – | – | – | 1.1 | 1.1 | 21 | -9.0 | 30 | 79 | -8.4 | 120 | -41 | -116 | -13 | -24 | 1.2 | -2.7 | 4.3 | -4.9 | 0.5 | -1.9 | 15 | -15 | -5.1 | 2.0 | -0.6 | 0.6 | 1.1 | -6.2 | 0.9 | -3.6 | |
| – | – | – | – | – | – | – | -8.4 | -8.4 | -9.0 | -9.0 | -5.3 | -12 | -12 | -20 | -15 | -19 | -17 | -17 | -12 | -17 | -9.4 | -10 | -9.9 | -16 | -11 | -8.8 | -10 | -9.4 | -10 | -9.1 | -3.3 | -15 | -12 | -40 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.